Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Addepalli Pavani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|August 2, 2014
Methodological issues in the development of a pharmacogenomic algorithm for warfarin dosing: comparison of two regression approachesAddepalli Pavani, Shaik Mohammad Naushad, Addepally Uma, et al.
Molecular Biology Reports|December 17, 2010
Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancerShaik Mohammad Naushad, Addepalli Pavani, Raghunadha Rao Digumarti, et al.
Pharmacological Reports : PR|April 20, 2019
Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant casesShaik Mohammad Naushad, Addepalli Pavani, Yedluri Rupasree, et al.
Pharmacogenomics|December 16, 2015
Artificial neural network-based pharmacogenomic algorithm for warfarin dose optimizationAddepalli Pavani, Shaik Mohammad Naushad, Rajasekar Manoj Kumar, et al.
Indian Journal of Biochemistry & Biophysics|November 8, 2011
Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer riskShaik Mohammad Naushad, Addepalli Pavani, Yedluri Rupasree, et al.
Pharmacogenomics|July 28, 2016
Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirementAddepalli Pavani, Shaik Mohammad Naushad, Ganapathy Lakshmitha, et al.
Pharmacogenomics|June 9, 2012
Retrospective evidence for clinical validity of expanded genetic model in warfarin dose optimization in a South Indian populationAddepalli Pavani, Shaik Mohammad Naushad, Ramesh C Mishra, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2019
Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemiaShaik Mohammad Naushad, Patchava Dorababu, Yedluri Rupasree, et al.
Pharmacogenomics|April 1, 2015
Mechanistic insights into the effect of CYP2C9*2 and CYP2C9*3 variants on the 7-hydroxylation of warfarinAddepalli Pavani, Shaik Mohammad Naushad, Balraj Alex Stanley, et al.
Cell Biochemistry and Biophysics|July 28, 2011
Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancerShaik Mohammad Naushad, Cheruku Apoorva Reddy, Yedluri Rupasree, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|August 2, 2014
Methodological issues in the development of a pharmacogenomic algorithm for warfarin dosing: comparison of two regression approachesAddepalli Pavani, Shaik Mohammad Naushad, Addepally Uma, et al.
Molecular Biology Reports|December 17, 2010
Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancerShaik Mohammad Naushad, Addepalli Pavani, Raghunadha Rao Digumarti, et al.
Pharmacological Reports : PR|April 20, 2019
Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant casesShaik Mohammad Naushad, Addepalli Pavani, Yedluri Rupasree, et al.
Pharmacogenomics|December 16, 2015
Artificial neural network-based pharmacogenomic algorithm for warfarin dose optimizationAddepalli Pavani, Shaik Mohammad Naushad, Rajasekar Manoj Kumar, et al.
Indian Journal of Biochemistry & Biophysics|November 8, 2011
Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer riskShaik Mohammad Naushad, Addepalli Pavani, Yedluri Rupasree, et al.
Pharmacogenomics|July 28, 2016
Development of neuro-fuzzy model to explore gene-nutrient interactions modulating warfarin dose requirementAddepalli Pavani, Shaik Mohammad Naushad, Ganapathy Lakshmitha, et al.
Pharmacogenomics|June 9, 2012
Retrospective evidence for clinical validity of expanded genetic model in warfarin dose optimization in a South Indian populationAddepalli Pavani, Shaik Mohammad Naushad, Ramesh C Mishra, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2019
Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemiaShaik Mohammad Naushad, Patchava Dorababu, Yedluri Rupasree, et al.
Pharmacogenomics|April 1, 2015
Mechanistic insights into the effect of CYP2C9*2 and CYP2C9*3 variants on the 7-hydroxylation of warfarinAddepalli Pavani, Shaik Mohammad Naushad, Balraj Alex Stanley, et al.
Cell Biochemistry and Biophysics|July 28, 2011
Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancerShaik Mohammad Naushad, Cheruku Apoorva Reddy, Yedluri Rupasree, et al.
Pageof 2